[1] Chaudhary P, Bhadana U, Singh RA, et al. Primary hepatic angiosarcoma[J]. Eur J Surg Oncol, 2015, 41(9):1137-1143. [2] 王湛博, 安晓静, 邓晋芳, 等. 肝脏恶性血管源性肿瘤中ERG、Fli-1、CD34、CD31、FⅧRAg的表达特征[J]. 中华病理学杂志, 2017, 46(11):760-763. [3] 王健, 李强, 崔云龙, 等. 肝血管肉瘤:16例回顾[J].中华肝胆外科杂志, 2006, 12(8):532-535. [4] Algashaamy K, Montgomery EA, Garcia-Buitrago M. Liver mesenchymal neoplasms: something old, something new[J]. Pathology, 2022, 54(2):225-235. [5] 孙金萍, 李海, 宋国新, 等. 原发性肝血管肉瘤6例临床病理分析[J]. 诊断病理学杂志, 2016, 23(1):19-22,26. [6] Bruegel M, Muenzel D, Waldt S, et al. Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI[J]. Abdominal Imaging, 2013, 38(4):745-754. [7] 孙璐, 石怀银, 韦立新. 原发性肝血管肉瘤临床病理观察[J]. 武警医学, 2012, 23(5):427-430. [8] 李霁, 常晓燕, 陈杰, 等. 原发性肝血管肉瘤3例病理及文献复习[J]. 协和医学杂志,2012, 03(1):84-88. [9] Liau JY, Tsai JH, Yang CY, et al. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas[J]. Hum Pathol,2015, 46(9):1360-1366. [10] Zheng YW, Zhang XW, Zhang JL, et al. Primary hepatic angiosarcoma and potential treatment options[J]. J Gastroenterol Hepatol,2014, 29(5):906-911. [11] Takashi K. Primary hepatic angiosarcoma: findings at CT and MR imaging[J]. Radiology,2002, 222(3):667-673. |